Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances

Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances

The incidence of hepatocellular carcinoma (HCC) ranks first among primary liver cancers, and its mortality rate exhibits a consistent annual increase. The treatment of HCC has witnessed a significant surge in recent years, with the emergence of targeted immune therapy as an adjunct to early surgical...

Full description

Bibliographic Details
Main Authors:	Xiang Wang, Zijun Yuan, Zhengbo Li, Xinyu He, Yinping Zhang, Xingyue Wang, Jiahong Su, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Shuai Deng, Yueshui Zhao, Jing Shen, Tao Yi, Zhangang Xiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Immunology
Subjects:	tumor-infiltrating lymphocytes (TILs) hepatocellular carcinoma (HCC) immunotherapy signaling pathway TILs preparation targeting neoantigens
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354313/full

Similar Items

The investigation of oncolytic viruses in the field of cancer therapy
by: Zijun Yuan, et al.
Published: (2024-07-01)

Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
by: Siqi Ren, et al.
Published: (2025-02-01)

Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma
by: Fang Wang, et al.
Published: (2022-10-01)

Therapeutic prospects of ceRNAs in COVID-19
by: Lin Liu, et al.
Published: (2022-09-01)

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities
by: Liyao Tang, et al.
Published: (2023-02-01)

Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer
by: Yalan Dai, et al.
Published: (2022-11-01)

Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing
by: Mintao Xiao, et al.
Published: (2022-11-01)

Fingerprint profiling for quality evaluation and the related biological activity analysis of polysaccharides from Liuweizhiji Gegen-Sangshen beverage
by: Shulin Wei, et al.
Published: (2024-07-01)

Organoid, organ-on-a-chip and traditional Chinese medicine
by: Jiayue Yang, et al.
Published: (2025-02-01)

Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma
by: Yifan Hu, et al.
Published: (2022-11-01)

Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review
by: Shuang Luo, et al.
Published: (2022-12-01)

Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma
by: Yao Chen, et al.
Published: (2022-10-01)

Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network
by: Mintao Xiao, et al.
Published: (2023-03-01)

HPV-associated cervicovaginal microbiome and host metabolome characteristics
by: Yao Zhang, et al.
Published: (2024-03-01)

Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
by: Jifang Zheng, et al.
Published: (2023-12-01)

Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma
by: Zhihua Ye, et al.
Published: (2024-07-01)

The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD‐L1 expression and tumor‐infiltrating lymphocytes
by: Lu Chen, et al.
Published: (2019-12-01)

Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma
by: Zhongling Sun, et al.
Published: (2024-04-01)

Quercitrin, the primary active ingredient of Albizia julibrissin Durazz. flowers, alleviates methamphetamine-induced hepatotoxicity through a mitochondria-mediated apoptosis pathway
by: Dan Wu, et al.
Published: (2025-03-01)

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
by: Mohammad Hossein Kazemi, et al.
Published: (2022-10-01)

Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer
by: Lu Liu, et al.
Published: (2024-01-01)

The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma
by: Mahshid Panahi, et al.
Published: (2023-01-01)

Excessive consumption of the sugar rich longan fruit promoted the development of nonalcoholic fatty liver disease via mediating gut dysbiosis
by: Xu Wu, et al.
Published: (2023-03-01)

Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
by: Pooja M. Vaid, et al.
Published: (2022-11-01)

Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
by: Guangrun Zhou, et al.
Published: (2022-07-01)

Glyoxalase 1 gene improves the antistress capacity and reduces the immune inflammatory response
by: Fukuan Du, et al.
Published: (2019-12-01)

Decoding the epitranscriptome: a new frontier for cancer therapy and drug resistance
by: Lu Tang, et al.
Published: (2024-10-01)

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis
by: Yajing Zhu, et al.
Published: (2022-11-01)

Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma
by: Tiantian Yu, et al.
Published: (2024-01-01)

Gegen-Sangshen oral liquid and its active fractions mitigate alcoholic liver disease in mice through repairing intestinal epithelial injury and regulating gut microbiota
by: Shulin Wei, et al.
Published: (2024-12-01)

Transcriptomic characterization revealed that METTL7A inhibits melanoma progression via the p53 signaling pathway and immunomodulatory pathway
by: Duoli Zhang, et al.
Published: (2023-08-01)

Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
by: Jiuping Zeng, et al.
Published: (2023-06-01)

Functional Heterogeneity of CD4+ Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC
by: Anna E. Oja, et al.
Published: (2018-11-01)

Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease
by: Yujie Lu, et al.
Published: (2023-08-01)

Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo
by: Jing Li, et al.
Published: (2024-01-01)

Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs
by: Jing Li, et al.
Published: (2022-09-01)

Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma
by: Wattawan Wongpattaraworakul, et al.
Published: (2022-07-01)

MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma
by: Yangyang Xu, et al.
Published: (2020-11-01)

PROTACs in gastrointestinal cancers
by: Yu Chen, et al.
Published: (2022-12-01)

IL-2RG is a predictor of prognosis and response to immune checkpoint blockages and is correlated with immune infiltrates in breast cancer
by: Yu Zheng, et al.
Published: (2023-11-01)